{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:40:10Z","timestamp":1648604410643},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00105-019-04479-0","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T09:02:36Z","timestamp":1569574956000},"page":"134-138","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Granulomat\u00f6se Rosazea bei einem Lungentransplantierten"],"prefix":"10.1007","volume":"71","author":[{"given":"Claudia","family":"Ansorge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Technau-Hafsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"issue":"11","key":"4479_CR1","doi-asserted-by":"publisher","first-page":"902","DOI":"10.2174\/1389200219666180329124130","volume":"19","author":"M Adil","year":"2018","unstructured":"Adil\u00a0M, Iqbal\u00a0W, Adnan\u00a0F, Wazir\u00a0S, Khan\u00a0I, Khayam\u00a0MU et\u00a0al (2018) Association of metronidazole with cancer: a potential risk factor or inconsistent deductions? Curr Drug Metab 19(11):902\u2013909","journal-title":"Curr Drug Metab"},{"issue":"2","key":"4479_CR2","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/ajt.13462","volume":"16","author":"RJ Chovatiya","year":"2016","unstructured":"Chovatiya\u00a0RJ, Colegio\u00a0OR (2016) Demodicosis in renal transplant recipients. Am J Transplant 16(2):712\u2013716","journal-title":"Am J Transplant"},{"issue":"8","key":"4479_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/exd.13143","volume":"26","author":"AD Holmes","year":"2017","unstructured":"Holmes\u00a0AD, Steinhoff\u00a0M (2017) Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics. Exp Dermatol 26(8):659\u2013667","journal-title":"Exp Dermatol"},{"issue":"10","key":"4479_CR4","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jfo.2011.07.008","volume":"34","author":"S L\u00e9oni","year":"2011","unstructured":"L\u00e9oni\u00a0S, Mespli\u00e9\u00a0N, Aitali\u00a0F, Chamaillard\u00a0M, Boralevi\u00a0F, Marques da Costa\u00a0C et\u00a0al (2011) Metronidazole: alternative treatment for ocular and cutaneous rosacea in the pediatric population. J\u00a0Fr Ophtalmol 34(10):703\u2013710","journal-title":"J Fr Ophtalmol"},{"issue":"1","key":"4479_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-4362.1988.tb02323.x","volume":"27","author":"PG Nielsen","year":"2007","unstructured":"Nielsen\u00a0PG (2007) Metronidazole treatment in rosacea. Int J Dermatol 27(1):1\u20135","journal-title":"Int J Dermatol"},{"issue":"8","key":"4479_CR6","first-page":"768","volume":"11","author":"M Reinholz","year":"2013","unstructured":"Reinholz\u00a0M, Tietze\u00a0JK, Kilian\u00a0K, Schaller\u00a0M, Sch\u00f6fer\u00a0H, Lehmann\u00a0P et\u00a0al (2013) Rosacea \u2013 S1 guideline. J\u00a0Dtsch Dermatol Ges 11(8):768\u2013779","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"4479_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s13555-016-0133-6","volume":"6","author":"M Schaller","year":"2016","unstructured":"Schaller\u00a0M, Dirschka\u00a0T, Kem\u00e9ny\u00a0L, Briantais\u00a0P, Jacovella\u00a0J (2016) Superior efficacy with ivermectin 1\u202f% cream compared to metronidazole 0.75\u202f% cream contributes to a\u00a0better quality of life in patients with severe papulopustular rosacea: a subanalysis of the randomized, investigator-blinded ATTRACT study. Dermatol Ther 6(3):427\u2013436","journal-title":"Dermatol Ther"},{"key":"4479_CR8","first-page":"29","volume":"6","author":"M Schaller","year":"2016","unstructured":"Schaller\u00a0M, Sch\u00f6fer\u00a0H, Homey\u00a0B, Gieler\u00a0U, Lehmann\u00a0P, Luger\u00a0TA et\u00a0al (2016) State of the art: systemic rosacea management. J\u00a0Dtsch Dermatol Ges 6:29\u201337","journal-title":"J Dtsch Dermatol Ges"},{"issue":"Suppl 6","key":"4479_CR9","first-page":"17","volume":"14","author":"M Schaller","year":"2016","unstructured":"Schaller\u00a0M, Sch\u00f6fer\u00a0H, Homey\u00a0B, Hofmann\u00a0M, Gieler\u00a0U, Lehmann\u00a0P et\u00a0al (2016) Rosacea management: update on general measures and topical treatment options. J\u00a0Dtsch Dermatol Ges 14(Suppl 6):17\u201327","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"4479_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s13555-017-0176-3","volume":"7","author":"S Thibaut de M\u00e9nonville","year":"2017","unstructured":"Thibaut de M\u00e9nonville\u00a0S, Rosignoli\u00a0C, Soares\u00a0E, Roquet\u00a0M, Bertino\u00a0B, Chappuis\u00a0J\u2011P et al (2017) Topical treatment of rosacea with ivermectin inhibits gene expression of cathelicidin innate immune mediators, LL-37 and KLK5, in reconstructed and ex vivo skin models. Dermatol Ther 7(2):213\u2013225","journal-title":"Dermatol Ther"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-019-04479-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-019-04479-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-019-04479-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T23:42:15Z","timestamp":1601077335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-019-04479-0"}},"subtitle":["Eine m\u00f6gliche Therapieoption bei einer besonderen Patientengruppe"],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["4479"],"URL":"https:\/\/doi.org\/10.1007\/s00105-019-04479-0","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]},"assertion":[{"value":"27 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Ansorge und K.\u00a0Technau-Hafsi geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}